Nonsteroidal anti-inflammatory drug Created 2026-10-31 Updated 2026-11-05
A nonsteroidal anti-inflammatory drug is a drug in the group including ibuprofen, naproxen and aspirin. These agents commonly reduce prostaglandin production through cyclooxygenase inhibition. Their shared pathway does not make their duration, selectivity or other effects identical.
Nystatin Created 2026-10-31 Updated 2026-11-05
Off-target drug effect Created 2026-10-20 Updated 2026-11-05
Opioid receptor 2026-11-05
An opioid receptor is a G protein-coupled receptor recognizing opioid ligands, including endogenous peptides and exogenous drugs. Major receptor classes differ in distribution and ligand responses. Their signalling commonly engages inhibitory G proteins, linking receptor activation to changes in cyclic-AMP production and ion-channel activity. [ref]
Molecular Biology of the Cell, 4th edition by Bruce Alberts and others. Chapter 15, G-protein-linked receptors and regulation of adenylyl cyclase and ion channels
The same bound ligand need not produce identical effects in every assay. Receptor abundance, coupling efficiency and downstream amplification affect observed efficacy. Experiments comparing candidate opioid agonists showed why low intrinsic G-protein efficacy can help explain apparently favourable signalling profiles, rather than assuming that every difference establishes a uniquely selective pathway. [ref]
Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists by Alexander Gillis and others. 2020, abstract: efficacy and interpretation of agonist signalling profiles
The assertion is too absolute: a remedy can cause a distant response through a reflex or another intervening physiological change without first being absorbed into the blood. It is substantially right for the direct action of a circulating drug on a distant target, but does not describe every remote effect of treatment.
Three mechanisms should be distinguished:
- Direct action after drug absorption. An orally administered drug that acts directly in the brain must gain access to that tissue. Absorption from the gastrointestinal tract, transport in the blood, and passage to the target explain such a systemic action. Changing the route changes the first step: a subcutaneous medicine must leave its local depot, whereas an intravenous medicine is introduced directly into the circulation. The literal word “absorbed” is consequently too restrictive even before considering reflexes.
- Local action followed by a neural response. Stimulation of sensory nerves at one surface can cause a response elsewhere through the nervous system. Gastric stimulation can evoke vomiting, including coordinated movement of respiratory and abdominal muscles; sensory input from the gastrointestinal tract reaches brainstem circuits through vagal afferents. No requirement follows that the original gastric irritant must itself circulate to every contracting muscle. A swallowed emetic can have more than one mechanism, however: an observed instance of vomiting alone does not prove that absorption played no part.[ref]Nausea and Vomiting Related to Cancer Treatment by the National Cancer Institute. “Pathophysiology of N&V”; visceral afferent inputs and output to abdominal musculature and respiratory centres
- Local action followed by a change in the body's contents. As a present-day illustration, an osmotic laxative can retain water in the intestinal lumen and promote evacuation with limited systemic absorption. Any secondary change in fluid balance or symptoms is then a consequence of the local intestinal action, not proof that the laxative has directly acted on a remote organ. The polyethylene glycol 3350 information from MedlinePlus describes retention of water in stool; the regulatory monograph records minimal absorption.[ref]Polyethylene Glycol 3350 by MedlinePlus. “Why is this medication prescribed?”; retention of water in stool[ref]PegLyte prescribing information. “Action and clinical pharmacology”, p. 9; mechanism and pharmacokinetics of PEG 3350
The distinction is between transport of the medicinal substance and transmission of its consequences. A reflex transmits activity in neurons; a locally acting intestinal agent changes a physical condition; a circulating drug delivers molecules to its distant target. The same remedy may combine these routes, and an apparently rapid effect does not by itself settle which route caused it.
A useful experimental design would therefore compare remote responses with measurements of the agent in blood, and would test the proposed neural pathway separately. In an appropriate physiological preparation, recording the response while interrupting a relevant afferent pathway can test whether that pathway is necessary; preserving the circulation while interrupting nerve conduction distinguishes neural transmission from vascular transport. Conversely, a remote effect after vascular transfer supports a circulating agent, provided contamination and other transferred mediators are controlled. Failure to detect a drug is only as strong as the analytical detection limit.
Absorption is one route to remote action, not a universal prerequisite for every distant physiological consequence. The historical language “animal economy” means the functioning organism; it should not conceal the distinction between a direct pharmacological effect and a secondary physiological response.
Penicillin G Created 2026-10-20 Updated 2026-11-05
A penicillin antibiotic, also called benzylpenicillin, that acts on bacterial cell wall synthesis. It is used as a reference substrate in some beta-lactamase measurements, separating an enzyme’s activity on one substrate from activity on the entire drug family.
Pharmacodynamics 2026-11-05
Pharmacodynamics describes how a drug changes a biological system as a function of exposure. It connects target binding to a measured response, whereas pharmacokinetics describes the time course of exposure. A simple illustrative model iswhere is the maximum increment above baseline and is the concentration producing half that increment. Doubling does not generally double the response. [ref]
Molecular Biology of the Cell, 4th edition by Bruce Alberts and others. Chapter 15, Cells Can Adjust Their Sensitivity to a Signal: receptor occupancy and cellular response
Potency and maximal effect differ: two drugs can have different values but the same , or the same but different maximal effects. Moreover, need not equal a binding dissociation constant, because downstream amplification and measurement time also shape the response.
Pharmacokinetics Created 2026-10-20 Updated 2026-11-05
Pharmacokinetics describes the time course of a drug and its metabolites in an organism, including drug absorption, distribution, metabolism and elimination. A concentration-time curve helps distinguish exposure from response: equal administered amounts can produce different concentrations at the target.
Pharmacological effect 2026-10-31
A change in biological function caused by a drug. Direct action at a target should be distinguished from a secondary physiological response.
Pharmacologist Created 2026-10-14 Updated 2026-11-05
A pharmacologist studies interactions between drugs and biological systems. Experiments can connect a molecular target to tissue responses or whole-organism effects. Establishing drug action requires specifying both the biological preparation and the exposure.
Pharmacology Created 2026-10-14 Updated 2026-11-05
Pharmacology studies how drugs interact with living systems. It connects molecular recognition, changes in physiology and the time course of exposure. Distinguishing what a substance does from how it reaches its targets is central to interpreting experiments.
Pharmacy Created 2026-10-31 Updated 2026-11-05
Pharmacy concerns the preparation, quality and supply of medicines. Formulation connects chemical identity to a usable pharmaceutical preparation; two products containing the same named drug need not have identical concentration or delivery properties.
Physostigmine 2026-11-05
Physostigmine is a carbamate alkaloid that inhibits acetylcholinesterase. Normally this enzyme hydrolyses acetylcholine; inhibition prolongs the availability of acetylcholine at cholinergic signalling sites. Physostigmine is therefore an indirect enhancer of cholinergic signalling, rather than simply a substitute ligand for every acetylcholine receptor. [ref]
PubChem Compound database by National Center for Biotechnology Information. Physostigmine, CID 5983, Pharmacology and Biochemistry: reversible cholinesterase inhibition
A mechanistic distinction matters: increasing transmitter persistence can affect both muscarinic and nicotinic signalling wherever transmitter release and susceptible receptors occur. The outcome therefore depends on location, receptor type and baseline activity. This example separates an enzyme-directed drug action from the eventual physiological response, without assuming one universal effect in every tissue.
Psychopharmacology Created 2026-10-24 Updated 2026-11-05
Pulvis Kino cum Opio Created 2026-10-31 Updated 2026-11-05
Pulvis Kino cum Opio is a compound powder combining kino and opium. The preparation joins chemically different plant-derived materials rather than one isolated drug.[ref]
The Essentials of Materia Medica and Therapeutics by Alfred Baring Garrod (1865). Pulvis Kino cum Opio, named preparation in the corresponding monograph
Santonin Created 2026-10-31 Updated 2026-11-05
Sedation Created 2026-10-31 Updated 2026-11-05
A drug-induced reduction in alertness and responsiveness. It spans different depths and is distinct from both analgesia and local anaesthesia; these effects can coexist without being equivalent.
Shitij Kapur Created 2026-10-25 Updated 2026-11-05
A researcher who proposed an aberrant-salience framework connecting dopamine signaling, psychosis and drug action. The contribution was a theoretical synthesis generating testable relationships, rather than a single experiment proving every causal link.[ref]
Researcher whose contributions include the work cited below.[ref]
https://pubmed.ncbi.nlm.nih.gov/12505794/. Identity and authorship record
Sodium valproate Created 2026-10-31 Updated 2026-11-05
Sodium valproate is the sodium salt of valproic acid, an antiseizure drug with several effects on neuronal signaling. Salt identity, active chemical species and clinical formulation are distinct levels of description; no single receptor interaction fully defines its action.
Syrup Created 2026-10-31 Updated 2026-11-05